Blue Jet Healthcare Ltd Stock Price Today (NSE: BLUEJET)
Fundamental Score
Blue Jet Healthcare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Blue Jet Healthcare Ltd share price today is ₹419.35, down 0.78% on NSE/BSE as of 20 April 2026. Blue Jet Healthcare Ltd (BLUEJET) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of ₹9.84K (Cr). The 52-week high for BLUEJET share price is ₹1027.80 and the 52-week low is ₹325.00. At a P/E ratio of 27.92x, BLUEJET is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 30.24% and a debt-to-equity ratio of 0.02.
Blue Jet Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Blue Jet Healthcare Share Price
The pharmaceutical industry is witnessing a shift towards specialized contract development and manufacturing organizations (CDMOs), driven by the increasing complexity of drug development and the need for efficient outsourcing. This trend forms the backdrop against which we analyze the Blue Jet Healthcare share price. Currently trading at ₹411.45, with a Price-to-Earnings (PE) ratio of 27.92 and a Return on Capital Employed (ROCE) of 39.75%, Blue Jet Healthcare presents an interesting case for evaluation. This analysis forms part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra.
A crucial aspect of financial stability is profitability and efficient capital allocation. The reported ROCE of 39.75% is significantly higher than the industry average, suggesting the company is adept at generating profits from its invested capital. This high ROCE strengthens Blue Jet Healthcare’s economic moat. It indicates a potential competitive advantage, possibly stemming from specialized product offerings, efficient operations, or strong customer relationships. This advantage allows them to reinvest profits at a high rate of return, potentially leading to sustained growth.
Benchmarking against its sector peers provides further context. Companies like
Mankind Pharma Ltd, Smruthi Organics Ltd, and Balaxi Pharmaceuticals Ltd, operate in similar spaces, but variations exist in their financial metrics and strategic focus. For instance, considering Mankind Pharma Ltd, while specific details aren't available within this analysis, observations about management quality could be made. Does Mankind Pharma Ltd exhibit a more conservative or aggressive approach to expansion? How do their research and development expenditures compare? These are crucial elements that require deeper investigation to contextualize Blue Jet Healthcare's performance.The PE ratio of 27.92 indicates the market’s expectation of future earnings growth. It's essential to analyze whether this expectation is justified based on factors like industry trends, competitive landscape, and the company’s internal capabilities. A thorough understanding of Blue Jet Healthcare’s financial health requires a deeper dive into its balance sheet, cash flow statement, and management commentary to assess its long-term sustainability and growth prospects. Observing the consistency of ROCE and comparing it to peers helps determine if the current share price accurately reflects the intrinsic value of the company.
Blue Jet Healthcare Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹344.90 | ₹359.85 | ₹335.00 | ₹357.35 | 4.13L (Cr) | |
| ₹335.00 | ₹355.85 | ₹335.00 | ₹351.00 | 4.66L (Cr) | |
| ₹341.10 | ₹343.00 | ₹325.00 | ₹327.25 | 9.13L (Cr) | |
| ₹353.40 | ₹353.75 | ₹337.75 | ₹343.80 | 8.03L (Cr) | |
| ₹353.85 | ₹362.70 | ₹349.50 | ₹353.40 | 7.37L (Cr) | |
| ₹350.00 | ₹352.85 | ₹337.55 | ₹348.25 | 5.90L (Cr) | |
| ₹358.00 | ₹374.90 | ₹335.80 | ₹341.30 | 16.55L (Cr) | |
| ₹366.40 | ₹375.35 | ₹351.10 | ₹357.95 | 6.57L (Cr) | |
| ₹375.00 | ₹379.55 | ₹363.35 | ₹365.50 | 5.66L (Cr) | |
| ₹353.95 | ₹387.85 | ₹353.00 | ₹383.30 | 11.73L (Cr) |
Blue Jet Healthcare Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹335.00 | ₹359.85 | ₹335.00 | ₹357.35 | +6.67% | |
| ₹393.05 | ₹399.90 | ₹325.00 | ₹327.25 | -16.74% | |
| ₹410.05 | ₹453.00 | ₹352.55 | ₹405.30 | -1.16% | |
| ₹532.00 | ₹541.15 | ₹411.10 | ₹417.75 | -21.48% | |
| ₹578.40 | ₹581.05 | ₹512.40 | ₹530.20 | -8.33% | |
| ₹661.00 | ₹688.50 | ₹538.00 | ₹578.45 | -12.49% | |
| ₹638.70 | ₹692.90 | ₹630.15 | ₹656.40 | +2.77% | |
| ₹667.90 | ₹759.50 | ₹628.40 | ₹630.15 | -5.65% | |
| ₹808.00 | ₹825.00 | ₹659.95 | ₹667.85 | -17.35% | |
| ₹879.90 | ₹1027.80 | ₹755.10 | ₹805.95 | -8.40% | |
| ₹900.00 | ₹986.00 | ₹847.50 | ₹877.75 | -2.47% | |
| ₹706.15 | ₹909.90 | ₹692.05 | ₹904.80 | +28.13% |
AI Research Briefing
Powered by Gemini · 2026-04-10
Blue Jet is a capacity expansion story masking near-term earnings weakness and promoter selling.
⚡WHAT'S HAPPENING NOW (last 2-4 weeks):
Blue Jet Healthcare's stock surged 9.99% on April 10, 2026, reaching an intraday high of ₹407.3, outperforming the Pharmaceuticals & Biotechnology sector by 8.2 percentage points. This reverses a recent downtrend. However, Q3FY26 results were weak, with net profit down 59.4% YoY to ₹401.66 million and revenue declining 39.6% to ₹1,924.14 million. The company held an earnings call on February 13, 2026. A groundbreaking ceremony for a new manufacturing facility in Andhra Pradesh with a planned investment of ₹1,000 crore was held on February 28, 2026.
�� CORE STORY (THE REAL GAME):
Blue Jet is being priced as a specialty pharmaceutical ingredient play, specifically in contrast media and high-intensity sweeteners, with potential upside from new capacity and R&D investments. However, near-term earnings are volatile.
- Recent price surge of 9.99% on April 10, 2026
- ₹1,000 crore investment in Vizag facility signals future growth
- Hyderabad R&D center expected to commence work from Q3 FY27
- Successful commissioning of Vizag facility
- Positive results from R&D pipeline
- Stabilization of gross margins
- Q3FY26 revenue decline of 39.6% and profit decline of 59.4%
- Promoter selling (down 6.19%)
- Mid-cap: liquidity risk
Promoter: 79.81% (Δ -6.19%) indicates negative sentiment. FII: 1.83% (Δ -0.14%), DII: 3.63% (Δ 2.68%) [cite: brief]
Indian pharma exports are growing, but face pricing pressures and trade uncertainties.
Blue Jet Healthcare commenced groundbreaking ceremony for new Vizag manufacturing facility with Board-approved Phase 1 investment of ₹1,000 crore.
Free Cash Flow 5Y: ₹326.48 Cr [cite: brief] - Profit converting to cash, but needs monitoring
Next 3-6 months hinge on execution of Vizag project and stabilization of earnings. Watch for margin improvement and new product launches.
Primary Thesis Risk
Failure to execute Vizag expansion will crush the narrative.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Blue Jet Healthcare Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Shareholding Pattern
Promoter
FII
DII
Pledged
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Blue Jet Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of BLUEJET across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (30.24%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (39.75%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (35.21%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (13.86% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (15.67% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.02)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (88.76x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹326.48 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Profit Decline Concern (-10.64%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-20.54%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-76.50% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Limited Institutional Interest (FII+DII: 5.46%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Peer Comparison - Pharmaceuticals
Compare Blue Jet Healthcare Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Blue Jet Healthcare LtdBlue Jet Health...Selected✓ BLUEJET • 544009 | 50.4/100 | ₹419.35₹419 | ₹9839.53₹9839.53 | 27.92Average 27.9 Average | 30.24%Excellent 30.24% Excellent | 39.75%Excellent 39.75% Excellent | 0.02Excellent 0.0 Excellent | 15.67%Excellent 15.67% Excellent | 13.86%Good 13.86% Good | 0.21% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1671.00₹1671 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 0.00%Poor 0.00% Poor | 0.07Excellent 0.1 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6286.50₹6287 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 0.00%Poor 0.00% Poor | 0.01Excellent 0.0 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4180.50₹4181 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 0.00%Poor 0.00% Poor | 0.33Excellent 0.3 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1237.20₹1237 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 0.00%Poor 0.00% Poor | 0.01Excellent 0.0 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1237.80₹1238 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 0.00%Poor 0.00% Poor | 0.16Excellent 0.2 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2335.10₹2335 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 0.00%Poor 0.00% Poor | 0.32Excellent 0.3 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹942.20₹942 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 0.00%Poor 0.00% Poor | 0.38Excellent 0.4 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2122.40₹2122 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 0.00%Poor 0.00% Poor | 0.55Good 0.6 Good | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1381.00₹1381 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 0.00%Poor 0.00% Poor | 0.22Excellent 0.2 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5652.00₹5652 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 0.00%Poor 0.00% Poor | 0.18Excellent 0.2 Excellent | 0.00%Average 0.00% Average | 0.00%Average 0.00% Average | 0.00% |
Blue Jet Healthcare Ltd Financial Statements
Comprehensive financial data for Blue Jet Healthcare Ltd including income statement, balance sheet and cash flow
About BLUEJET (Blue Jet Healthcare Ltd)
Blue Jet Healthcare Ltd is a dynamic force in the pharmaceutical landscape, specializing in the intricate art of crafting high-value pharmaceutical intermediates and active pharmac...eutical ingredients (APIs). Their expertise lies in developing and manufacturing complex molecules that serve as essential building blocks for a wide spectrum of therapeutic applications. Beyond simple production, Blue Jet prides itself on mastering challenging chemistries and navigating the complexities of regulatory compliance, ensuring the quality and purity of its products. They are committed to driving innovation within the pharmaceutical supply chain by delivering specialized intermediates and APIs that empower drug manufacturers to create life-enhancing medications. The company’s core strength stems from its dedication to precision and customization. Blue Jet not only provides established pharmaceutical building blocks but also excels in the development of niche intermediates tailored to the unique needs of its clients. This involves a deep understanding of the evolving demands of the pharmaceutical industry and a commitment to staying ahead of the curve with innovative manufacturing processes. Their focus on customized solutions extends to offering comprehensive support throughout the drug development lifecycle, from early-stage research to large-scale commercial production, forging strong and lasting partnerships with pharmaceutical companies. With a focus on excellence and an unwavering commitment to quality, Blue Jet Healthcare aims to be a reliable and trusted partner for pharmaceutical companies worldwide. They are committed to ensuring the consistent delivery of high-quality pharmaceutical intermediates and APIs that meet stringent regulatory requirements. The company’s drive for continuous improvement in manufacturing processes, combined with a strong dedication to customer satisfaction, positions them as a forward-thinking player in the pharmaceutical industry. By focusing on innovation and reliability, Blue Jet Healthcare is dedicated to contributing to the advancement of healthcare solutions globally.
Company Details
Key Leadership
Corporate Events
BLUEJET Share Price: Frequently Asked Questions
What is the current share price of Blue Jet Healthcare Ltd?
As of 20 Apr 2026, 08:28 am IST, Blue Jet Healthcare Ltd share price is ₹419.35. The Blue Jet Healthcare Ltd stock has a market capitalisation of ₹9.84K (Cr) on NSE/BSE.
Is Blue Jet Healthcare Ltd share price Overvalued or Undervalued?
Blue Jet Healthcare Ltd share price is currently trading at a P/E ratio of 27.92x, compared to the industry average of 31.77x. Based on this relative valuation, the Blue Jet Healthcare Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of Blue Jet Healthcare Ltd share price?
The 52-week high of Blue Jet Healthcare Ltd share price is ₹1027.80 and the 52-week low is ₹325.00. These values are updated daily from NSE/BSE price data.
What factors affect the Blue Jet Healthcare Ltd share price?
Key factors influencing Blue Jet Healthcare Ltd share price include quarterly earnings growth (Sales Growth: -20.54%), raw material costs, government spending, and institutional flows (FII/DII holding).
Is Blue Jet Healthcare Ltd a good stock for long-term investment?
Blue Jet Healthcare Ltd shows a 5-year Profit Growth of 15.67% and an ROE of 30.24%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.02 before investing in Blue Jet Healthcare Ltd shares.
How does Blue Jet Healthcare Ltd compare with its industry peers?
Blue Jet Healthcare Ltd competes with major peers in the Pharmaceuticals. Investors should compare Blue Jet Healthcare Ltd share price P/E of 27.92x and ROE of 30.24% against the industry averages to determine competitive standing.
What is the P/E ratio of Blue Jet Healthcare Ltd and what does it mean?
Blue Jet Healthcare Ltd share price has a P/E ratio of 27.92x compared to the industry average of 31.77x. Investors pay ₹28 for every ₹1 of annual earnings.
How is Blue Jet Healthcare Ltd performing according to Bull Run's analysis?
Blue Jet Healthcare Ltd has a Bull Run fundamental score of 50.4/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does Blue Jet Healthcare Ltd belong to?
Blue Jet Healthcare Ltd operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Blue Jet Healthcare Ltd share price.
What is Return on Equity (ROE) and why is it important for BLUEJET?
BLUEJET has an ROE of 30.24%, which indicates excellent management efficiency. ROE measures how efficiently Blue Jet Healthcare Ltd generates profits from shareholders capital.
How is BLUEJET debt-to-equity ratio and what does it indicate?
BLUEJET has a debt-to-equity ratio of 0.02, which indicates conservative financing with low financial risk.
What is BLUEJET dividend yield and is it a good dividend stock?
BLUEJET offers a dividend yield of 0.21%, meaning you receive ₹0.21 annual dividend for every ₹100 invested in Blue Jet Healthcare Ltd shares.
How has BLUEJET share price grown over the past 5 years?
BLUEJET has achieved 5-year growth rates of: Sales Growth 13.86%, Profit Growth 15.67%, and EPS Growth -76.50%.
What is the promoter holding in BLUEJET and why does it matter?
Promoters hold 79.81% of BLUEJET shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Blue Jet Healthcare Ltd.
What is BLUEJET market capitalisation category?
BLUEJET has a market capitalisation of ₹9840 crores, placing it in the Mid-cap category.
How volatile is BLUEJET stock?
BLUEJET has a beta of N/A. A beta > 1 suggests the Blue Jet Healthcare Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is BLUEJET operating profit margin trend?
BLUEJET has a 5-year average Operating Profit Margin (OPM) of 35.21%, indicating the company's operational efficiency.
How is BLUEJET quarterly performance?
Recent quarterly performance shows Blue Jet Healthcare Ltd YoY Sales Growth of -20.54% and YoY Profit Growth of -10.64%.
What is the institutional holding pattern in BLUEJET?
BLUEJET has FII holding of 1.83% and DII holding of 3.63%. Significant institutional holding often suggests professional confidence in the Blue Jet Healthcare Ltd stock.